Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Rituparna Sinha Roy"'
Autor:
Snehasish Ghosh, Sanchita Mukherjee, Chiranjit Dutta, Kasturee Chakraborty, Paramita Gayen, Somnath Jan, Dhananjay Bhattacharyya, Rituparna Sinha Roy
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Abstract Designing biologically inspired nanoscale molecular assembly with desired functionality is a challenging endeavour. Here we report the designing of fibrin-inspired nanostructured peptide based sealants which facilitate remarkably fast entrap
Externí odkaz:
https://doaj.org/article/14d09943b727411a9021042d9db8b705
Autor:
Kasturee Chakraborty, Abhijit Biswas, Sukumar Mishra, Argha Mario Mallick, Archana Tripathi, Somnath Jan, Rituparna Sinha Roy
Publikováno v:
ACS Applied Bio Materials. 6:458-472
Autor:
Kasturee Chakraborty, Archana Tripathi, Sukumar Mishra, Argha Mario Mallick, Rituparna Sinha Roy
Publikováno v:
Bioscience Reports. 42
Nanotherapy has emerged as an improved anticancer therapeutic strategy to circumvent the harmful side effects of chemotherapy. It has been proven to be beneficial to offer multiple advantages, including their capacity to carry different therapeutic a
Autor:
Argha M. Mallick, Archana Tripathi, Sukumar Mishra, Asmita Mukherjee, Chiranjit Dutta, Ananya Chatterjee, Rituparna Sinha Roy
Publikováno v:
Chemistry – An Asian Journal. 17
RNA interference (RNAi) is a primitive evolutionary mechanism developed to escape incorporation of foreign genetic material. siRNA has been instrumental in achieving the therapeutic potential of RNAi by theoretically silencing any gene of interest in
Autor:
Rituparna Sinha Roy, Argha Mario Mallick, Somnath Jan, Paramita Gayen, Vinod Kumar, Anyam Vijay Kishore, Samit Kumar Nandi, Asmita Mukherjee, Snehasish Ghosh
Publikováno v:
ACS Biomaterials Science & Engineering. 6:6378-6393
Engineering bioinspired peptide-based molecular medicine is an emerging paradigm for the management of traumatic coagulopathies and inherent bleeding disorder. A hemostat-based strategy in managing uncontrolled bleeding is limited due to the lack of
Autor:
Monjuri Hembram, Rituparna Sinha Roy, Somnath Jan, Paramita Gayen, Nilkanta Chowdhury, Snehasish Ghosh, Angshuman Bagchi
Publikováno v:
Chemistry, an Asian journal. 16(24)
Developing non-immunogenic therapeutic biomolecules for facilitating blood clotting followed by wound healing via therapeutic angiogenesis, still remains a formidable challenge. Excessive blood loss of accident victims and battalions cause a huge num
Autor:
Somnath Jan, Sanchita Mukherjee, Dhananjay Bhattacharyya, Chiranjit Dutta, Kasturee Chakraborty, Rituparna Sinha Roy, Paramita Gayen, Abhijit Biswas, Argha Mario Mallick
Publikováno v:
ACS Applied Materials & Interfaces. 11:4719-4736
Cytosolic delivery of functional siRNA remains the major challenge to develop siRNA-based therapeutics. Designing clinically safe and effective siRNA transporter to deliver functional siRNA across the plasma and endosomal membrane remains a key hurdl
Publikováno v:
RSC Med Chem
Traumatic coagulopathy due to severe external injury and internal hemorrhage is life-threatening to accident victims and soldiers on the battlefield, causing considerable number of deaths worldwide. Patients with inherited bleeding disorders (such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afdeb227b8e749708ea6a01245ebc628
https://europepmc.org/articles/PMC7651999/
https://europepmc.org/articles/PMC7651999/
Autor:
Souvik Dey, Somnath Jan, Suprabhat Sahoo, Chiranjit Dutta, Rituparna Sinha Roy, Kishan Mandal, Argha Mario Mallick, Abhijit Biswas, Kasturee Chakraborty
Publikováno v:
Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach ISBN: 9789813298156
Peptides have emerged as powerful platform technologies to engineer effective therapies against cancer. Peptides play significant role as clinically important molecules in developing next-generation cancer therapeutics by targeting signalling pathway
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::707ae746e13b3a26b82843c67e3a4be7
https://doi.org/10.1007/978-981-32-9816-3_2
https://doi.org/10.1007/978-981-32-9816-3_2
Publikováno v:
European Polymer Journal. 73:237-246
Main chain chiral poly(methacrylate)s have been synthesized by controlled reversible addition–fragmentation chain transfer (RAFT) copolymerization of chiral monomer Boc- l -alanine methacryloyloxyethyl ester (Boc- l -Ala-HEMA, A) with Boc- d -alani